Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Boehringer Ingelheim Gubra to develop anti-obesity peptide poly agonists

      Drug Development
      Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity. It will bring together...

      Lantheus, NanoMab to offer novel biomarker to develop immuno-oncology therapies

      Drug Development
      Lantheus Holdings has collaborated with NanoMab Technology to provide a novel biomarker for clinical development and management of immuno-oncology therapies. As part of strategic collaboration...

      LYNPARZA delivers 72per ORR in phase 3 SOLO3 trial in advanced ovarian cancer

      Clinical Trials
      AstraZeneca and Merck presented full results from the Phase 3 SOLO3 trial which evaluated LYNPARZA, compared to chemotherapy, for the treatment of platinum-sensitive relapsed...

      ProtoKinetix achieves primary objective safety at midpoint of clinical trial

      Clinical Trials
      ProtoKinetix, announced reaching the midpoint of a Phase-1 first-in-human clinical trial of AAGP PKX-001 treated islet cells used in conjunction with the Edmonton Protocol...

      Janssen partners with nference for AI-based drug development

      Americas
      nference, a leader in knowledge synthesis software solutions for the life sciences industry announced a multi-year alliance with Janssen Research & Development, LLC that...

      AstraZeneca s Calquence shows superiority to chemotherapy in CLL

      Drug Development
      AstraZeneca has announced Calquence (acalabrutinib) reached both its primary and secondary endpoints in chronic lymphocytic leukaemia (CLL). In preliminary analysis of the Phase III ELEVATE-TN...

      Samsung BioLogics Enters New Era with First-of-its-kind Client-Centric CMO Deal

      Manufacturing
      Samsung BioLogics (SBL) recently entered a new era by signing a "first of its kind" deal with a US bio-pharmaceutical company valued at $7.8...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.